JP2019528063A5 - - Google Patents

Download PDF

Info

Publication number
JP2019528063A5
JP2019528063A5 JP2019508929A JP2019508929A JP2019528063A5 JP 2019528063 A5 JP2019528063 A5 JP 2019528063A5 JP 2019508929 A JP2019508929 A JP 2019508929A JP 2019508929 A JP2019508929 A JP 2019508929A JP 2019528063 A5 JP2019528063 A5 JP 2019528063A5
Authority
JP
Japan
Prior art keywords
body fluid
fluid sample
cfdna
amount
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019508929A
Other languages
English (en)
Japanese (ja)
Other versions
JP7109424B2 (ja
JP2019528063A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/047372 external-priority patent/WO2018035340A1/en
Publication of JP2019528063A publication Critical patent/JP2019528063A/ja
Publication of JP2019528063A5 publication Critical patent/JP2019528063A5/ja
Application granted granted Critical
Publication of JP7109424B2 publication Critical patent/JP7109424B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019508929A 2016-08-17 2017-08-17 体液に基づくセルフリーDNA(cfDNA)アッセイを通して臓器損傷状態を査定するための新規のイムノプローブに基づく方法 Active JP7109424B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662376299P 2016-08-17 2016-08-17
US62/376,299 2016-08-17
PCT/US2017/047372 WO2018035340A1 (en) 2016-08-17 2017-08-17 A novel immunoprobe-based method to assess organ injury status through a biofluid-based cell-free dna (cfdna) assay

Publications (3)

Publication Number Publication Date
JP2019528063A JP2019528063A (ja) 2019-10-10
JP2019528063A5 true JP2019528063A5 (enExample) 2020-10-15
JP7109424B2 JP7109424B2 (ja) 2022-07-29

Family

ID=61197090

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019508929A Active JP7109424B2 (ja) 2016-08-17 2017-08-17 体液に基づくセルフリーDNA(cfDNA)アッセイを通して臓器損傷状態を査定するための新規のイムノプローブに基づく方法

Country Status (7)

Country Link
US (7) US11124824B2 (enExample)
EP (2) EP3845665A1 (enExample)
JP (1) JP7109424B2 (enExample)
CN (2) CN109890977A (enExample)
AU (1) AU2017313138B2 (enExample)
CA (1) CA3033650A1 (enExample)
WO (1) WO2018035340A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
CA2824387C (en) 2011-02-09 2019-09-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
WO2014113204A1 (en) 2013-01-17 2014-07-24 Personalis, Inc. Methods and systems for genetic analysis
US20180173846A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
WO2016070131A1 (en) 2014-10-30 2016-05-06 Personalis, Inc. Methods for using mosaicism in nucleic acids sampled distal to their origin
US11168351B2 (en) 2015-03-05 2021-11-09 Streck, Inc. Stabilization of nucleic acids in urine
DK3294906T3 (en) 2015-05-11 2024-08-05 Natera Inc Methods for determining ploidy
US20170145475A1 (en) 2015-11-20 2017-05-25 Streck, Inc. Single spin process for blood plasma separation and plasma composition including preservative
WO2017181202A2 (en) 2016-04-15 2017-10-19 Natera, Inc. Methods for lung cancer detection
US11299783B2 (en) 2016-05-27 2022-04-12 Personalis, Inc. Methods and systems for genetic analysis
EP3491381B1 (en) 2016-07-29 2025-09-24 Streck LLC Suspension composition for hematology analysis control
CA3033650A1 (en) 2016-08-17 2018-02-22 The Regents Of The University Of California A novel immunoprobe-based method to assess organ injury status through a biofluid-based cell-free dna (cfdna) assay
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
HUE068517T2 (hu) 2017-10-19 2024-12-28 Streck Llc A hemolízis és a véralvadás szabályozására, valamint az extracelluláris vezikulák stabilizálására szolgáló készítmények
CA3085933A1 (en) 2017-12-14 2019-06-20 Tai Diagnostics, Inc. Assessing graft suitability for transplantation
EP3781714B1 (en) 2018-04-14 2026-01-07 Natera, Inc. Methods for cancer detection and monitoring by means of personalized detection of circulating tumor dna
US10801064B2 (en) 2018-05-31 2020-10-13 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
US11814750B2 (en) 2018-05-31 2023-11-14 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
US12234509B2 (en) * 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
EP4397771A3 (en) * 2019-01-04 2024-10-16 PreAnalytiX GmbH Urine stabilization
EP3914731A1 (en) * 2019-01-24 2021-12-01 Illumina, Inc. Methods and systems for monitoring organ health and disease
EP4055610A4 (en) 2019-11-05 2023-11-29 Personalis, Inc. ESTIMATION OF TUMOR PURITY FROM SINGLE SAMPLES
US11980636B2 (en) 2020-11-18 2024-05-14 Jazz Pharmaceuticals Ireland Limited Treatment of hematological disorders
EP4263383A4 (en) * 2020-12-17 2024-10-23 Nephrosant, Inc. KITS FOR STABILIZATION OF URINE SAMPLES
US20240279720A1 (en) * 2021-07-23 2024-08-22 Georgetown University Use of genetic and epigenetic markers to detect cell death
EP4413580A4 (en) 2021-10-05 2025-08-13 Personalis Inc PERSONALIZED TESTS FOR PERSONALIZED CANCER MONITORING
WO2023101886A1 (en) * 2021-11-30 2023-06-08 Nephrosant, Inc. Generative adversarial network for urine biomarkers
CN119677869A (zh) 2022-09-16 2025-03-21 伊路米纳有限公司 具有多核苷酸结合位点的纳米颗粒及其制备方法
WO2025076525A1 (en) * 2023-10-06 2025-04-10 Neutrolis, Inc. Biomarker and precision therapy for inflammatory disease

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0821041B2 (ja) 1988-06-01 1996-03-04 横河電機株式会社 プリント基板cadの部品シンボル作成方法
US5849517A (en) 1991-05-08 1998-12-15 Streck Laboratories, Inc. Method and composition for preserving antigens and nucleic acids and process for utilizing cytological material produced by same
JPH0821041A (ja) 1994-07-07 1996-01-23 Ig Tech Res Inc 瓦棒葺屋根の改修構造
ATE247176T1 (de) * 1994-12-29 2003-08-15 Eiken Chemical Verfahren zur zellerkennung
JPH1021041A (ja) * 1996-06-28 1998-01-23 Matsushita Electric Ind Co Ltd 操作パネル
US7537889B2 (en) * 2003-09-30 2009-05-26 Life Genetics Lab, Llc. Assay for quantitation of human DNA using Alu elements
US20090280479A1 (en) * 2005-05-27 2009-11-12 John Wayne Cancer Institute Use of free circulating dna for diagnosis, prognosis, and treatment of cancer funding
WO2009042457A1 (en) 2007-09-21 2009-04-02 Streck, Inc. Nucleic acid isolation in preserved whole blood
JP2010017178A (ja) * 2008-06-11 2010-01-28 Sumitomo Chemical Co Ltd Dnaを定量又は検出する方法
ES2649572T3 (es) 2009-02-18 2018-01-12 Streck Inc. Conservación de ácidos nucleicos fuera de las células
US8404444B2 (en) 2009-02-25 2013-03-26 Diacarta Llc Method for predicting the level of damage to cells by measuring free circulating Alu nucleic acid
US20110027771A1 (en) 2009-07-31 2011-02-03 Artemis Health, Inc. Methods and compositions for cell stabilization
CA2780536C (en) * 2009-11-09 2018-01-02 Streck, Inc. Stabilization of rna in and extracting from intact cells within a blood sample
KR20120123056A (ko) 2009-12-20 2012-11-07 아스튜트 메디컬 인코포레이티드 신손상 및 신부전을 진단 및 예측하는 방법 및 조성물
WO2012108538A1 (ja) * 2011-02-10 2012-08-16 国立大学法人 長崎大学 急性肺損傷診断方法
JP5214042B2 (ja) 2012-02-03 2013-06-19 アンリツ株式会社 光素子パッケージの製造方法
US10472679B2 (en) * 2012-05-15 2019-11-12 Cornell University Non-invasive method of diagnosing renal fibrosis
WO2014029791A1 (en) 2012-08-21 2014-02-27 Qiagen Gmbh Method for isolating nucleic acids from a formaldehyde releaser stabilized sample
WO2014029792A1 (en) 2012-08-21 2014-02-27 Qiagen Gmbh Virus particle stabilisation and method for isolating viral nucleic acids
WO2014074501A1 (en) * 2012-11-06 2014-05-15 Quest Diagnostics Investments Incorporated Molecular markers for diagnosis of acute cellular rejection and acute tubular necrosis
CN105102634A (zh) * 2013-03-15 2015-11-25 伊穆科Gti诊治股份有限公司 使用尿的无细胞dna评价肾状态的方法和组合物
CN105121643A (zh) * 2013-03-18 2015-12-02 凯杰有限公司 细胞外核酸的稳定化和分离
EP3041955A4 (en) * 2013-09-06 2017-05-03 Immucor GTI Diagnostics, Inc. Compositions and methods for diagnosis and prediction of solid organ graft rejection
SI4026917T1 (sl) * 2014-04-14 2024-05-31 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. Metoda in komplet za določanje smrti celic ali tkiva oz. izvora DNK tkiva ali celice z analizo metilacije DNK
US20170159127A1 (en) 2014-04-24 2017-06-08 Euroclone S.P.A. An in vitro diagnostic method of cancer
CA2954576C (en) 2014-07-09 2020-08-11 Daniel ENDERLE Methods for isolating microvesicles and extracting nucleic acids from biological samples
EP3497232A1 (en) * 2016-08-12 2019-06-19 Streck, Inc. Molecular reference controls
CA3033650A1 (en) 2016-08-17 2018-02-22 The Regents Of The University Of California A novel immunoprobe-based method to assess organ injury status through a biofluid-based cell-free dna (cfdna) assay

Similar Documents

Publication Publication Date Title
JP2019528063A5 (enExample)
Barker et al. Limitations of using feline coronavirus spike protein gene mutations to diagnose feline infectious peritonitis
Nicot et al. Diversity of hepatitis E virus genotype 3
JP2008249727A5 (enExample)
CN102181575A (zh) 用于检测乙型肝炎病毒耐药突变位点的引物及方法
CN111187860A (zh) 新型冠状病毒多重pcr快速检测试剂盒
CN105506182B (zh) 一种猪病毒性腹泻病毒5重rt-pcr检测试剂盒
JP2015530868A5 (enExample)
CN103866050B (zh) 猪流行性腹泻病毒荧光定量pcr检测方法及其引物
WO2018210201A1 (zh) 一种用于早期诊断、预测脓毒血症并发急性肾损伤的分子标记物、试剂盒及应用
CN111455114A (zh) SARS-CoV-2的高通量检测试剂盒
Simanavicius et al. Detection of rat hepatitis E virus, but not human pathogenic hepatitis E virus genotype 1–4 infections in wild rats from Lithuania
CA3116522A1 (en) A method of detecting small rna
CN107699638A (zh) 一种检测猫杯状病毒的方法
CN103805717B (zh) 一种用于检测I型和IV型马疱疹病毒的双重Eva Green实时荧光定量PCR检测试剂盒及其应用
CN104774918A (zh) 基于实时荧光pcr的il28b基因多态性检测试剂盒
CN110029160B (zh) 一种基于血浆lncRNA组合物的肺结核病疗效评价试剂盒及其用途
CN102344970A (zh) 同时检测人cmv和bk病毒dna的引物序列及定量检测试剂盒
CN119287079A (zh) 核酸组合、丁型肝炎病毒核酸检测试剂及其应用
JP5845489B2 (ja) B型肝炎ウイルス群を検出し、遺伝子多様性を評価するためのオリゴヌクレオチドのセット、並びにそれを用いた方法
CN111690772A (zh) 一种新冠病毒核酸检测试剂盒、制备方法及应用
CN105112568A (zh) 基于焦磷酸测序的鲤春病毒血症病毒检测试剂盒
CN111411169A (zh) 用于恒温扩增检测麻疹病毒的核酸序列、试剂盒及方法和应用
CN116064960A (zh) 用于prrsv谱系1c变异株荧光rt-pcr检测的引物探针组、试剂盒及其检测方法
López-Palacios et al. SARS-COV-2 viral RNA detection through oligonucleotide-capped nanoporous anodic alumina supports.